ArticleJournal of clinical medicine2020

miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro.

Markus Krebs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.